Atlas Trials

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects

Clinical trial NCT07169240 · COMPLETED

Trial details

NCT number
NCT07169240
Sponsor
ScinnoHub Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects (HS)
Start date
2023-02-06
Primary completion
2024-04-17
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.